ATM News Network: Virbac, a global leader in animal health, has announced the acquisition of Globion, a prominent Indian poultry vaccines specialist. This strategic move reinforces Virbac's position as a market leader in animal health in India and expands its poultry portfolio to include avian vaccines.
Established in 2005 as a joint venture between the Suguna Group, a leading Indian poultry conglomerate, and Lohmann Animal Health, a German poultry vaccines specialist, Globion has gained significant expertise in the development, manufacturing, and commercialization of live and inactivated vaccines targeting various avian pathogens. Headquartered in Hyderabad, Globion operates with approximately 120 full-time employees and generates an annual revenue of around €12 million.
Sébastien Huron, CEO of Virbac Group, expressed his enthusiasm about the acquisition, stating, "We are extremely pleased to welcome the Globion team into our Virbac family. This acquisition aligns with our 2030 Virbac vision and strategy for growth through strategic mergers and acquisitions, particularly in the field of vaccines. It enhances our leadership in India, the world's most populous country, and expands our product portfolio to cater to the dynamic and promising poultry market. We are committed to supporting the Globion team with the necessary resources to excel and create long-term value for our customers."
B. Soundararajan, founder and managing director of Suguna Group, shared his thoughts on the partnership, saying, "We started Globion primarily as a source of high-quality, affordable poultry vaccines for Suguna Foods. Over the last decade, Globion has evolved into a fast-growing poultry biologicals company with consistent market share growth in India and export markets. By joining forces with a strategic partner like Virbac, with a long-term vision, infrastructure, and deep understanding of animal health in both Indian and global markets, we see tremendous potential for Globion to achieve greater heights. Virbac is the right choice for us as it shares our vision of adding value to the poultry industry."
This acquisition represents a significant step in Virbac's dedication to animal health and the expansion of its product offerings in India and beyond. Veda Corporate Advisors served as the advisors to Suguna and Globion in this transaction.
Virbac, operating in more than 100 countries, is committed to improving the quality of life for animals by providing innovative solutions to veterinarians, breeders, and animal owners, covering a wide range of species and pathologies.